ARCHIVES

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

Should Be Cut First, DCT Board Says

December 4, 1981

Has To Plan International Meeting On Threat If DNA Biohazards

September 13, 1974

Opposition To Lederberg May Have Caused Delay In Panel Appointments; FY 19809 Funds Held Up

October 5, 1979

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

Committee, BSC Recommend Against Continuing Women’s Health Trial; Appeal to NCAB Seen

January 15, 1988

In Brief: Survey Finds Americans Misinformed About Leading Cause Of Cancer Death

July 10, 1998